
Novavax, Inc. (NVAX)
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn more- Previous Close
7.93 - Open
7.90 - Bid 8.01 x 500
- Ask 8.07 x 700
- Day's Range
7.86 - 8.08 - 52 Week Range
5.80 - 11.97 - Volume
2,978,820 - Avg. Volume
4,052,622 - Market Cap (intraday)
1.322B - Beta (5Y Monthly) 2.65
- PE Ratio (TTM)
3.12 - EPS (TTM)
2.58 - Earnings Date May 6, 2026
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
14.00
Recent News: NVAX
View MorePerformance Overview: NVAX
Trailing total returns as of 5/1/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Earnings Trends: NVAX
View MoreAnalyst Insights: NVAX
View MoreStatistics: NVAX
View MoreValuation Measures
-
Market Cap
1.32B
-
Enterprise Value
835.72M
-
Trailing P/E
3.12
-
Forward P/E
--
-
PEG Ratio (5yr expected)
--
-
Price/Sales (ttm)
1.24
-
Price/Book (mrq)
33.20
-
Enterprise Value/Revenue
0.74
-
Enterprise Value/EBITDA
1.70
Financial Highlights
Profitability and Income Statement
-
Profit Margin
39.19%
-
Return on Assets (ttm)
25.72%
-
Return on Equity (ttm)
--
-
Revenue (ttm)
1.12B
-
Net Income Avi to Common (ttm)
440.3M
-
Diluted EPS (ttm)
2.58
Balance Sheet and Cash Flow
-
Total Cash (mrq)
735.08M
-
Total Debt/Equity (mrq)
--
-
Levered Free Cash Flow (ttm)
-331.94M
Compare To: NVAX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.









